The Seed Stage Surge: Health Tech Funds and the Rise of Virtual-First Chronic Care Management (2026)
For years, digital health was synonymous with “telehealth”—a simple video overlay on top of traditional, fragmented care. But as we move through 2026, a more profound transformation has taken hold at the seed stage. We have entered the era of Virtual-First Care (V1C).
Unlike the first generation of digital health, V1C startups are not “software companies that help doctors.” They are digitally-native clinical enterprises that take full accountability for patient outcomes. Driven by a new wave of specialized seed-stage funds, these startups are redesigning the longitudinal journey for the one in three adults living with multiple chronic conditions.
I. The Investment Thesis: Why Chronic Care?
In 2026, the “low-hanging fruit” of urgent care and mental health has been plucked. The massive $12B Virtual Care Management market is now pivoting toward the most expensive and complex patient populations.
The CCM/RPM Synergy
The primary driver of the 2026 surge is the stabilization of the “Financial Flywheel.” Seed-stage investors are prioritizing startups that successfully combine Chronic Care Management (CCM) with Remote Patient Monitoring (RPM). With the widespread adoption of the 2026 CPT 99470 code—which incentivizes integrated virtual specialty care—startups can now project predictable, recurring revenue from the moment they sign a payer contract. This “SaaS-like” predictability in a clinical setting is exactly what seed funds like Kindred Ventures and Pear VC are looking for.
II. The New Seed-Stage “Heavyweights”
The 2026 seed landscape is dominated by funds that have moved beyond “generalist” tech and into deep “health-tech infrastructure.”
- General Catalyst: Through
